Phreesia, Inc. (NYSE:PHR) SVP Sells $75,867.48 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 3,354 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $75,867.48. Following the sale, the senior vice president now owns 123,463 shares of the company’s stock, valued at $2,792,733.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Amy Beth Vanduyn also recently made the following trade(s):

• On Tuesday, January 16th, Amy Beth Vanduyn sold 738 shares of Phreesia stock. The shares were sold at an average price of $24.55, for a total transaction of $18,117.90.

Phreesia Trading Up 2.1 %

Shares of NYSE:PHR opened at $23.80 on Friday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. The stock’s 50-day moving average is $24.76 and its 200-day moving average is $21.09. The company has a market cap of $1.34 billion, a P/E ratio of -9.44 and a beta of 0.92. Phreesia, Inc. has a 52-week low of $12.05 and a 52-week high of $34.98.

Phreesia (NYSE:PHR) last released its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter last year, the firm posted ($0.72) EPS. The company’s revenue was up 24.0% on a year-over-year basis. Equities research analysts predict that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Analyst Ratings Changes

PHR has been the topic of a number of research reports. Robert W. Baird upped their price target on shares of Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, March 18th. JMP Securities upped their target price on Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Thursday, March 21st. DA Davidson reiterated a “neutral” rating and set a $32.00 price target on shares of Phreesia in a report on Friday, March 15th. Raymond James restated an “outperform” rating and issued a $30.00 price objective (up previously from $25.00) on shares of Phreesia in a report on Friday, March 15th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a research note on Thursday, March 21st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $31.62.

Hedge Funds Weigh In On Phreesia

Institutional investors and hedge funds have recently bought and sold shares of the stock. International Assets Investment Management LLC boosted its holdings in Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after purchasing an additional 1,411 shares during the period. Captrust Financial Advisors raised its position in shares of Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after buying an additional 866 shares during the last quarter. Acadian Asset Management LLC bought a new stake in shares of Phreesia in the first quarter valued at about $43,000. State of Wyoming lifted its stake in shares of Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after buying an additional 493 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in Phreesia by 85.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after acquiring an additional 1,445 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.